Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Locally advanced basal cell carcinoma (laBCC) is a more severe subtype of BCC, characterized by large, deeply invasive tumors that often occur in cosmetically or functionally sensitive areas. Mohs micrographic surgery (MMS) is the standard treatment, offering high cure rates through layer-by-layer excision with microscopic margin control. However, MMS alone may not entirely prevent recurrence in aggressive or infiltrative subtypes. Photodynamic therapy (PDT) is a non-invasive treatment modality that may enhance outcomes when used adjunctively. This study evaluated whether combining MMS with PDT offers advantages over MMS alone for laBCC.

Method: A retrospective cohort study was conducted with 63 patients diagnosed with laBCC, categorized by histological subtype into aggressive and non-aggressive groups. Patients were not randomized; they received either MMS alone or MMS followed by PDT based on clinical decision-making at treatment time. Clinical outcomes were analyzed, including recurrence, recurrence-free survival (RFS), and surgical margins.

Results: MMS group exhibited a low recurrence rate of 4.4 %, against 22.2 % for MMS+PDT group. Non-aggressive tumours such as superficial, nodular, and adenoid types, treated with MMS and PDT had a 16.7 % recurrence rate, compared to 25 % for aggressive tumours, including Infiltrating, Basosquamous, and morphea form types. This suggests that non-aggressive cases may respond better to PDT. Additionally, the mean recurrence-free survival(mRFS) time was about 54 months (95 % CI: 50- 57.3 months) for non-aggressive tumours, while aggressive tumours had a mean survival of 52.3 months (95 % CI: 51-56.2 months), indicating a potential trend favouring non-aggressive tumours.

Conclusion: MMS combined with PDT show favourable outcomes in non-aggressive BBC.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pdpdt.2025.104633DOI Listing

Publication Analysis

Top Keywords

mms pdt
12
mms
9
mohs micrographic
8
micrographic surgery
8
photodynamic therapy
8
locally advanced
8
advanced basal
8
basal cell
8
cell carcinoma
8
recurrence rate
8

Similar Publications

Background: Locally advanced basal cell carcinoma (laBCC) is a more severe subtype of BCC, characterized by large, deeply invasive tumors that often occur in cosmetically or functionally sensitive areas. Mohs micrographic surgery (MMS) is the standard treatment, offering high cure rates through layer-by-layer excision with microscopic margin control. However, MMS alone may not entirely prevent recurrence in aggressive or infiltrative subtypes.

View Article and Find Full Text PDF

Setting up a global SARS-CoV-2 surveillance system requires an understanding of how virus isolation and propagation practices, use of animal or human sera, and different neutralisation assay platforms influence assessment of SARS-CoV-2 antigenicity. In this study, with the contribution of 15 independent laboratories across all WHO regions, we carried out a controlled analysis of neutralisation assay platforms using the first WHO International Standard for antibodies to SARS-CoV-2 variants of concern (source: NIBSC). Live virus isolates (source: WHO BioHub or individual labs) or spike plasmids (individual labs) for pseudovirus production were used to perform neutralisation assays using the same serum panels.

View Article and Find Full Text PDF

Purpose: To evaluate the efficacy of Mohs micrographic surgery (MMS) combined with photodynamic therapy (PDT) in treating non-invasive extramammary Paget's disease (EMPD).

Materials And Methods: A 77-year-old male patient with non-invasive EMPD was treated with MMS followed by PDT. Preoperative fluorescence localization using 5-aminolevulinic acid (ALA) was performed to determine the surgical scope.

View Article and Find Full Text PDF

Basal cell carcinoma (BCC) is the most common skin cancer, for which there are multiple treatment options, including the gold standard Mohs micrographic surgery (MMS), surgical excision, electrodesiccation and curettage, radiation therapy, cryosurgery, and photodynamic therapy (PDT). While PDT is currently approved for treating actinic keratosis, it has been used off-label to treat BCC patients who may not tolerate surgery or other treatment modalities. We present a review of the efficacy of these modalities and describe important considerations that affect the usage of PDT and MMS.

View Article and Find Full Text PDF

Introduction: Perineal extramammary paget's disease (EMPD) is characterized with high recurrence rate. Although numerous therapeutic measures for this disease have been reported so far, it is unknown whether there is significant difference in their recurrence-preventing efficiency. This study aims to compare the recurrence outcomes of reported perineal EMPD treatments.

View Article and Find Full Text PDF